Cargando…
Patients’ view on gene therapy development for lysosomal storage disorders: a qualitative study
INTRODUCTION: Several new treatment modalities are being developed for lysosomal storage disorders (LSDs), including gene therapy. As the currently available treatment options and their influence on disease progression differ greatly within the spectrum of LSDs, willingness to undergo gene therapy m...
Autores principales: | Eskes, Eline C. B., Beishuizen, Cathrien R. L., Corazolla, Eleonore M., van Middelaar, Tessa, Brands, Marion M. M. G., Dekker, Hanka, van de Mheen, Erica, Langeveld, Mirjam, Hollak, Carla E. M., Sjouke, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587648/ https://www.ncbi.nlm.nih.gov/pubmed/36271424 http://dx.doi.org/10.1186/s13023-022-02543-y |
Ejemplares similares
-
Engaging older people in an internet platform for cardiovascular risk self-management: a qualitative study among Dutch HATICE participants
por: van Middelaar, Tessa, et al.
Publicado: (2018) -
Registries for orphan drugs: generating evidence or marketing tools?
por: Hollak, Carla E. M., et al.
Publicado: (2020) -
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies
por: Aerts, Johannes M. F. G., et al.
Publicado: (2011) -
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
por: Platt, Frances M., et al.
Publicado: (2012) -
Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
por: Hollak, Carla EM, et al.
Publicado: (2011)